Applied AI research lab building RNA foundation models to predict disease progression and treatment response for pharma teams.
Blank Bio is an applied AI research lab training RNA foundation models on bulk RNA-seq data to enable precision oncology for pharma companies. Their two core applications are disease trajectory modeling—predicting how a patient's disease progresses over time using molecular profiles to enable smaller, more efficient clinical trials—and patient selection, identifying biological differences to find patients most likely to respond to a given therapy and uncovering resistance mechanisms. The team includes researchers from Recursion, Deep Genomics, DeepMind, Amazon, Memorial Sloan Kettering, and Stanford. Blank Bio is a product of Blank Bio.